Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam
The developed biphasic-release MUTs provide rapid onset, sustained LOX delivery, and reliable dose flexibility, representing a promising oral formulation for LOX therapy.
Authors
- Yuan Zeng (ORCID: https://orcid.org/0000-0002-3270-2459)
- Qiongzhi Shi
- Xiangyang Xie (ORCID: https://orcid.org/0000-0001-8260-3988)
- Yanchen Wang (ORCID: https://orcid.org/0000-0002-1215-2277)
- Man Han
- Hui Liu
- Yang Liu
- Ze-chun Long
Institutions
- Hubei University of Medicine (CN)
- Wuhan University of Technology (CN)
- Wuhan Wudong Hospital (CN)
- Zhuzhou Central Hospital (CN)
- Central Hospital of Wuhan (CN)
- Wuhan General Hospital of Guangzhou (CN)
- Wuhan University of Science and Technology (CN)
Publication Details
- Journal
- Drugs in R&D
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1007/s40268-026-00540-1
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Hunan Province